Real-time, in vivo rodent imaging, allows researchers to observe and monitor several normal and abnormal biological processes. Data collected using the eyes™ series, provides crucial initial insights and generate quantitative results that, in combination with the Visual | eyes™ interface, compose an essential platform for every preclinical laboratory.
Oncology
Non-invasively assess your agent's targeting properties, real-time monitor drug delivery and track tumor progression.
Infection, Inflammation
Acquire detailed insights into disease mechanisms, enhance more accurate diagnostics while supporting the development or improvement of new or already existing therapeutics.
Protocol optimization
Test different animal preparation conditions, drug concentrations and administration routes to optimize your protocols.
Quick insights
Scan the same mouse at multiple time points to determine the optimal moments for 3D imaging. Conduct super-fast QC to exclude faulty injected subjects from further and more complex studies.
Applications with eyes™
Oncology
Dynamic ⁶⁸Ga-FAPI 4D PET imaging
Following radiotracer distribution from the first minutes post injection in a U87MG tumor model
Image info: 0-60 min post injection – frame duration down to 2 min – 9 MBq injected activity
Study performed in BIOEMTECH LaboratoriesOncology, beta emitters
Longitudinal low-activity 3D SPECT imaging of ¹⁷⁷Lu-Trastuzumab
Following radiopharmaceutical distribution over time, even as available activity decreases
Image info: longitudinal imaging from 2 to 120 h p.i. – 30 min scans – injected activity 0.4MBq – activity during imaging down to 0.11 MBq
Study performed in BIOEMTECH Laboratories